PM-EV RNA cargo associated with Epithelial-Mesenchymal transition, glycolysis, and hypoxia. »
02/07/25

ESR1 mutations generate neoantigens in hormone-receptor positive metastatic breast cancers. »
02/07/25

SBRT showed satisfactory LC with low toxicity. »
02/06/25

MMP inhibitor or proteinase treatment blocked EV-mediated SMAD signaling. »
02/06/25

Multimodal treatment strategy results in significantly prolonged OS and DF. »
02/22/25

miR-503 acts as oncogene in malignant mesothelioma. »
02/22/25

ENT1-mediated adenosine uptake as important mechanism of adenosine-mediated immunosuppression. »
06/06/24

TP53 was most commonly mutated gene in all groups. »
12/13/24

GnRH antagonist and low-dose EMP yielded better BCR-free survival outcomes. »
02/05/25

KRAS G12C and G12D mutations demonstrate distinct clinical characteristics and treatment responses. »
01/30/25